Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients

NCT03895762 · clinicaltrials.gov ↗

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Breakthrough Cancer Pain

Interventions

DRUG: Abstral Oral Disintegrating Tablet (ODT)

Sponsor

A.Menarini Asia-Pacific Holdings Pte Ltd